Christopher Gibson - 07 Feb 2024 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Signature
/s/ Jonathan Golightly, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
07 Feb 2024
Net transactions value
-$367,481
Form type
4
Filing time
09 Feb 2024, 17:34:07 UTC
Previous filing
05 Jan 2024
Next filing
13 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Conversion of derivative security $0 +10,000 +1.3% $0.000000 801,725 07 Feb 2024 Direct F1, F2
transaction RXRX Class A Common Stock Gift $0 -10,000 -1.2% $0.000000 791,725 07 Feb 2024 Direct F1
transaction RXRX Class A Common Stock Options Exercise $77,500 +31,250 +3.9% $2.48 822,975 07 Feb 2024 Direct F1
transaction RXRX Class A Common Stock Sale $444,981 -48,272 -5.9% $9.22 774,703 07 Feb 2024 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXRX Stock Option (Right to Buy) Options Exercise $0 -31,250 -8.3% $0.000000 343,750 07 Feb 2024 Class A Common Stock 31,250 $2.48 Direct F1, F6
transaction RXRX Class B Common Stock Conversion of derivative security $0 -10,000 -0.15% $0.000000 6,471,496 07 Feb 2024 Class A Common Stock 10,000 $0.000000 Direct F1, F7, F8
holding RXRX Stock Option (Right to Buy) 813,600 07 Feb 2024 Class A Common Stock 0 $8.55 Direct F4
holding RXRX Stock Option (Right to Buy) 5,436 07 Feb 2024 Class A Common Stock 0 $11.40 Direct
holding RXRX Stock Option (Right to Buy) 407,676 07 Feb 2024 Class A Common Stock 0 $11.40 Direct F5
holding RXRX Class B Common Stock 515,000 07 Feb 2024 Class A Common Stock 0 $0.000000 by LAHWRAN-3 LLC F8, F9
holding RXRX Class B Common Stock 408,000 07 Feb 2024 Class A Common Stock 0 $0.000000 by LAHWRAN-4 LLC F8, F10
holding RXRX Class B Common Stock 118,875 07 Feb 2024 Class A Common Stock 0 $0.000000 by Gibson Family Trust F8, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 22, 2022.
F2 Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a bona-fide gift of shares by the Reporting Person
F3 This transaction was executed in multiple trades at prices ranging from $9.07 to $9.39. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F5 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F6 The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F7 Represents the conversion of Class B Common Stock into Class A Common Stock.
F8 Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
F9 The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
F10 The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
F11 The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.